Lipoic acid in secondary progressive MS: A randomized controlled pilot trial.
about
Lipoic Acid Stimulates cAMP Production in Healthy Control and Secondary Progressive MS Subjects.Longitudinal optical coherence tomography study of optic atrophy in secondary progressive multiple sclerosis: Results from a clinical trial cohort.Early alpha-lipoic acid therapy protects from degeneration of the inner retinal layers and vision loss in an experimental autoimmune encephalomyelitis-optic neuritis model.
P2860
Lipoic acid in secondary progressive MS: A randomized controlled pilot trial.
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Lipoic acid in secondary progressive MS: A randomized controlled pilot trial.
@ast
Lipoic acid in secondary progressive MS: A randomized controlled pilot trial.
@en
type
label
Lipoic acid in secondary progressive MS: A randomized controlled pilot trial.
@ast
Lipoic acid in secondary progressive MS: A randomized controlled pilot trial.
@en
prefLabel
Lipoic acid in secondary progressive MS: A randomized controlled pilot trial.
@ast
Lipoic acid in secondary progressive MS: A randomized controlled pilot trial.
@en
P2093
P2860
P1476
Lipoic acid in secondary progressive MS: A randomized controlled pilot trial.
@en
P2093
Charles Murchison
Dennis Bourdette
Elizabeth Heriza
Jack Simon
Katherine Powers
Michelle Cameron
Rebecca Spain
Vijayshree Yadav
P2860
P356
10.1212/NXI.0000000000000374
P577
2017-06-28T00:00:00Z